Neurocrine Biosciences (NBIX) Times Interest Earned (2017 - 2024)
Neurocrine Biosciences (NBIX) reported Times Interest Earned of $90.27 for Q1 2024, up 186.95% on a YoY basis from $31.46 in Q2 2023, and down 33.93% quarter-over-quarter from $136.64 in Q4 2023.
Neurocrine Biosciences (NBIX) Times Interest Earned (2017 - 2024) Analysis & Trends
Neurocrine Biosciences has reported Times Interest Earned for 8 years, with the latest figure at $90.27 in Q1 2024.
- For the quarter ending Q1 2024, Times Interest Earned rose 186.95% year-over-year to $90.27; the trailing twelve-month figure through Dec 2024 stood at $518.64 (up 850.87% YoY), and the FY2023 full-year result was $54.54, up 55.53% from the prior year.
- Times Interest Earned for Q1 2024 stood at $90.27, down from $136.64 in the prior quarter.
- The five-year high for Times Interest Earned was $136.64 in Q4 2023, with the low at -$103.82 in Q1 2023.
- Historically, Times Interest Earned has averaged $31.65 across 5 years, with a median of $9.23 in 2020.
- Annual changes were most pronounced in 2022 — Times Interest Earned jumped 1809.09% — and 2023, when it slumped 8807.33%.
- Neurocrine Biosciences' Times Interest Earned stood at $9.21 in 2020, then tumbled by 159.75% to -$5.5 in 2021, then jumped by 1809.09% to $94.0 in 2022, then soared by 45.36% to $136.64 in 2023, then sank by 33.93% to $90.27 in 2024.
- The last three Times Interest Earned figures came in at $90.27 (Q1 2024), $136.64 (Q4 2023), and $128.36 (Q3 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 13.44 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 108.60 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 5.39 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.31 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 16.72 |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | 9.47 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 90.27 |
| Dec 31, 2023 | 136.64 |
| Sep 30, 2023 | 128.36 |
| Jun 30, 2023 | 56.62 |
| Mar 31, 2023 | -103.82 |
| Dec 31, 2022 | 94.00 |
| Sep 30, 2022 | 73.17 |
| Jun 30, 2022 | 24.86 |
| Mar 31, 2022 | 1.19 |
| Dec 31, 2021 | -5.50 |
| Sep 30, 2021 | 6.74 |
| Jun 30, 2021 | 10.13 |
| Mar 31, 2021 | 4.92 |
| Dec 31, 2020 | 9.21 |
| Sep 30, 2020 | -5.21 |
| Jun 30, 2020 | 9.23 |
| Mar 31, 2020 | 7.18 |
| Dec 31, 2019 | 5.95 |
| Sep 30, 2019 | 11.26 |
| Jun 30, 2019 | 4.35 |